Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae

Maleux, Geert; Vander Mijnsbrugge, Ward; Henroteaux, Denis; Laenen, Annouschka; Cornelissen, Sandra; Claes, Kathleen; Fourneau, Inge; Verbeeck, Nicolas

doi:10.1016/j.jvir.2017.10.023

Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae

Author:

Maleux, Geert

Vander Mijnsbrugge, Ward ; Henroteaux, Denis ; Laenen, Annouschka ; Cornelissen, Sandra ; Claes, Kathleen ; Fourneau, Inge ; Verbeeck, Nicolas

Keywords:

Science & Technology, Life Sciences & Biomedicine, Radiology, Nuclear Medicine & Medical Imaging, Peripheral Vascular Disease, Cardiovascular System & Cardiology, DRUG-ELUTING BALLOONS, ARTERIOVENOUS-FISTULAS, RESTENOSIS, STENOSES, OUTCOMES, PATENCY, Aged, Aged, 80 and over, Angioplasty, Balloon, Arteriovenous Shunt, Surgical, Coated Materials, Biocompatible, Female, Graft Occlusion, Vascular, Humans, Male, Middle Aged, Paclitaxel, Prospective Studies, Recurrence, Treatment Outcome, Vascular Patency, HEMODIALYSIS ARTERIOVENOUS-FISTULAS, 1103 Clinical Sciences, Nuclear Medicine & Medical Imaging, 3202 Clinical sciences

Abstract:

To investigate the potential added value of paclitaxel-coated balloon (PCB) angioplasty to reduce fistula dysfunction related to recurrent stenoses in patients undergoing hemodialysis.